Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum-Reference-Cited by-同舟云学术

Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum

Published:2021-04-20 Issue:8 Volume:7 Page:2362-2369
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Fiedler Sebastian¹^ORCID,Piziorska Monika A.¹,Denninger Viola¹,Morgunov Alexey S.¹,Ilsley Alison¹,Malik Anisa Y.¹,Schneider Matthias M.²^ORCID,Devenish Sean R. A.¹,Meisl Georg²^ORCID,Kosmoliaptsis Vasilis³⁴⁵,Aguzzi Adriano⁶,Fiegler Heike¹,Knowles Tuomas P. J.²⁷^ORCID

Affiliation:

1. Fluidic Analytics, Unit A, The Paddocks Business Centre, Cherry Hinton Road, Cambridge CB1 8DH, United Kingdom

2. Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, United Kingdom

3. Department of Surgery, University of Cambridge, Addenbrookes Hospital, Cambridge CB2 0QQ, United Kingdom

4. NIHR Blood and Transplant Research Unit in Organ Donation and Transplantation, University of Cambridge, Hills Road, Cambridge CB2 0QQ, United Kingdom

5. NIHR Cambridge Biomedical Research Centre, Hills Road, Cambridge CB2 0QQ, United Kingdom

6. Institute of Neuropathology, University of Zurich, 8091 Zurich, Switzerland

7. Cavendish Laboratory, Department of Physics, University of Cambridge, JJ Thomson Ave, Cambridge CB3 0HE, United Kingdom

Funder

National Institute for Health Research

H2020 European Research Council

Biotechnology and Biological Sciences Research Council

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link